The Canadian Cholangiocarcinoma Collaborative (C3) is a partnership among patients, caregivers, oncologists and researchers which was formed to grow hope in patients and families affected by cholangiocarcinoma. Through a dedicated Research Navigator, the C3 provides patient support, Canadian specific resources, access to expert opinions, and opportunities to participate in on-going research programs. The C3 was founded in 2023 and is funded through a Canadian Cancer Society (CCS) and Canadian Institutes of Health Research (CIHR) Breakthrough Team Grant.
For more information please visit the C3 website or get in touch.
Email: info@cholangio.ca
Website: https://www.cholangio.ca
Socials: